HoneyMedical OÜ

Active Registry code 14515601 OÜ Pärnu linn Registered 28 Jun 2018
Compare

HoneyMedical OÜ is a OÜ based in Pärnu linn, registry code 14515601, status: active. Main activity: Manufacture of medicines and other pharmaceutical preparations. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Revenue · 2024 0 €
    industry median 25 284 € · companies in the industry: 24

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 234 187 € · above 2% of the industry
0100 000200 000300 000400 000500 000Q4 2023 Company: 0 € Industry median: 102 827 €Q4·23Q1 2024 Company: 0 € Industry median: 160 070 €Q2 2024 Company: 0 € Industry median: 216 097 €Q2·24Q3 2024 Company: 0 € Industry median: 261 493 €Q4 2024 Company: 0 € Industry median: 198 576 €Q4·24Q1 2025 Company: 0 € Industry median: 231 372 €Q2 2025 Company: 0 € Industry median: 292 853 €Q2·25Q3 2025 Company: 0 € Industry median: 423 731 €Q4 2025 Company: 0 € Industry median: 410 601 €Q4·25Q1 2026 Company: 0 € Industry median: 375 496 €Q2 2026 Company: 0 € Industry median: 198 786 €Q2·26Q3 2026 Company: 0 € Industry median: 234 187 €Q3·260100 000200 000300 000400 000500 000Q4 2024 Company: 0 € Industry median: 198 576 €Q1 2025 Company: 0 € Industry median: 231 372 €Q1·25Q2 2025 Company: 0 € Industry median: 292 853 €Q3 2025 Company: 0 € Industry median: 423 731 €Q3·25Q4 2025 Company: 0 € Industry median: 410 601 €Q1 2026 Company: 0 € Industry median: 375 496 €Q1·26Q2 2026 Company: 0 € Industry median: 198 786 €Q3 2026 Company: 0 € Industry median: 234 187 €Q3·26
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — —
Q2 2026 — — — —
Q1 2026 — — — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 — — — —
Q1 2025 — — — —
Q4 2024 — — — —
Q3 2024 — — — —
Q2 2024 — — — —
Q1 2024 — — — —
Q4 2023 — — — —
Q3 2023 — — — —
Q2 2023 — — — —
Q1 2023 — — — —
Q4 2022 — — — —
Q3 2022 — — — —
Q2 2022 — — — —
Q1 2022 — — — —

Financials by year

2018 – 2024
Revenue, € 2024: 0 € · industry median 25 284 € · above 5% of the industry
010 00020 00030 0002018 Company: — Industry median: —20182019 Company: 208 € Industry median: 28 809 €20192020 Company: 0 € Industry median: 25 207 €20202021 Company: 0 € Industry median: 11 877 €20212022 Company: — Industry median: 4 897 €20222023 Company: 0 € Industry median: 3 851 €20232024 Company: 0 € Industry median: 25 284 €2024010 00020 00030 0002018 Company: — Industry median: —20182019 Company: 208 € Industry median: 28 809 €2020 Company: 0 € Industry median: 25 207 €20202021 Company: 0 € Industry median: 11 877 €2022 Company: — Industry median: 4 897 €20222023 Company: 0 € Industry median: 3 851 €2024 Company: 0 € Industry median: 25 284 €2024
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2024: 0 € · industry median 0 € · above 45% of the industry
-1 00001 0002 0003 0004 0002018 Company: — Industry median: —20182019 Company: 3 655 € Industry median: 2 812 €20192020 Company: -10 € Industry median: 97 €20202021 Company: -59 € Industry median: 0 €20212022 Company: — Industry median: 0 €20222023 Company: 0 € Industry median: 0 €20232024 Company: 0 € Industry median: 0 €2024-1 00001 0002 0003 0004 0002018 Company: — Industry median: —20182019 Company: 3 655 € Industry median: 2 812 €2020 Company: -10 € Industry median: 97 €20202021 Company: -59 € Industry median: 0 €2022 Company: — Industry median: 0 €20222023 Company: 0 € Industry median: 0 €2024 Company: 0 € Industry median: 0 €2024
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2024: 45 € · +0.0% vs 2023
01 0002 0003 0002018 Company: —20182019 Company: 2 554 €20192020 Company: 2 544 €20202021 Company: 2 545 €20212022 Company: 2 545 €20222023 Company: 45 €20232024 Company: 45 €202401 0002 0003 0002018 Company: —20182019 Company: 2 554 €2020 Company: 2 544 €20202021 Company: 2 545 €2022 Company: 2 545 €20222023 Company: 45 €2024 Company: 45 €2024
Equity, € 2024: -1 414 € · +0.0% vs 2023
-2 000-1 00001 0002 0002018 Company: —20182019 Company: 1 155 €20192020 Company: 1 145 €20202021 Company: 1 086 €20212022 Company: 1 086 €20222023 Company: -1 414 €20232024 Company: -1 414 €2024-2 000-1 00001 0002 0002018 Company: —20182019 Company: 1 155 €2020 Company: 1 145 €20202021 Company: 1 086 €2022 Company: 1 086 €20222023 Company: -1 414 €2024 Company: -1 414 €2024
Employees 2024: 0 · industry median 32 · above 2% of the industry
0102030402018 Company: 0 Industry median: —20182019 Company: 0 Industry median: 3420192020 Company: 0 Industry median: 32.520202021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —20222023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 3220240102030402018 Company: 0 Industry median: —20182019 Company: 0 Industry median: 342020 Company: 0 Industry median: 32.520202021 Company: 0 Industry median: —2022 Company: 0 Industry median: —20222023 Company: 0 Industry median: 252024 Company: 0 Industry median: 322024
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2024 0 0 0 45 -1 414 0
2023 0 0 0 45 -1 414 0
2022 — — 0 2 545 1 086 0
2021 0 -59 0 2 545 1 086 0
2020 0 -10 0 2 544 1 145 0
2019 208 3 655 0 2 554 1 155 0
2018 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2024

Return on assets (ROA)
0.0 %
Net profit / assets
Equity ratio
-3 142.2 %
Equity / assets
Debt ratio
3 242.2 %
Liabilities / assets
Current ratio
0.92
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2024 1 Jan 2024 – 31 Dec 2024 9 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 18 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 4 Apr 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 3 May 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 25 May 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 30 Oct 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 21201Manufacture of medicines and other pharmaceutical preparations Main
Rulings
Number, date Title Deadline State Document
Ä 50097108 / 2
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 50097108 / M1
9 May 2022
Warning of a fine: annual report not filed 8 Jun 2022 Deficiencies eliminated
11 May 2022
PDF
Ä 50097108
28 Jun 2018
First entry In force
28 Jun 2018
PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data